Why the study?
Does coronary-artery bypass grafting improve survival in patients with multivessel coronary disease?
Population
Patients with multivessel coronary disease, especially those with more severe coronary disease, diabetes, or…
Design
Review
Authors
Loading...
Informs revascularization decisions in high-risk multivessel disease; leaves open need for contemporary RCTs.
Does coronary-artery bypass grafting improve survival in patients with multivessel coronary disease?
CABG improves survival in patients with multivessel coronary disease, with the greatest benefit seen in high-risk subgroups such as those with diabetes or left ventricular dysfunction.
Alexander et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: